A medical device lawfully marketed in Europe does not automatically qualify for commercial import into India. An Indian importer must first establish the product’s regulatory status and Indian risk classification, identify an eligible authorised agent, and follow the applicable Central Drugs Standard Control Organisation import pathway. European conformity evidence can support regulatory documentation, but it does not replace Indian authorisation.
Before shipment, the parties must also address manufacturer records, Indian labelling and customs preparation. Once devices reach West Bengal, compliant sale, storage, distribution, traceability and post-market controls create additional responsibilities under the applicable Indian regulatory framework.
Start With the Device, Not Its European Approval
India regulates medical devices under the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017, as amended. Import planning should therefore begin with the product’s status under Indian requirements rather than its commercial description or European classification.
Review the device’s:
- intended purpose and indications;
- operating principle;
- accessories and variants;
- software functions, where relevant;
- sterile or non-sterile status;
- measuring function;
- manufacturing site;
- models intended for India; and
- IVD status, where applicable.
An accessory, software product or diagnostic item may require regulatory treatment based on its intended medical purpose. Consequently, importers should settle product identity before preparing forms, labels or customs documents.
European Union classification also does not determine the Indian classification automatically. Indian rules apply their own classification principles.
Determine the Indian Risk Classification
India uses four risk classes for medical devices: Class A represents low risk, Class B low-moderate risk, Class C moderate-high risk and Class D high risk. The Medical Devices Rules also establish classification principles for IVDs.
Classification affects the regulatory route, supporting evidence and scrutiny. Therefore, importers should not infer an Indian class simply because European documentation describes a product under a particular EU MDR or IVDR class.
Classification Depends on Intended Purpose and Risk
For non-IVD devices, classification analysis can consider characteristics such as invasiveness, duration of contact, whether a device remains active or non-active, implantability and interaction with the human body.
IVDs follow separate classification principles that consider their diagnostic purpose and associated risk. Accordingly, an analyser, reagent, software component and implant should not receive the same classification reasoning merely because each qualifies as a medical device.
Where classification remains uncertain, the applicant should resolve the Indian position before filing rather than forcing European terminology into an Indian application.
CE Marking Does Not Replace Indian Approval
CE marking demonstrates conformity with the applicable European framework, subject to the route relevant to that device. However, it does not operate as an Indian import licence.
European documents can still carry regulatory value. CDSCO’s import documentation framework recognises regulatory certificates, quality certificates, declarations of conformity and relevant European conformity documentation as supporting material in applicable circumstances.
The distinction matters commercially. A shipment should not proceed merely because the manufacturer holds CE documentation. Instead, the Indian regulatory pathway must reach the required stage before commercial import.
Likewise, a Free Sale Certificate, marketing authorisation and CE documentation serve different evidentiary functions. Importers should not use those expressions interchangeably.
Identify an Eligible Indian Authorised Agent
For the standard import-licence pathway, Rule 34 requires an authorised agent holding a licence to manufacture for sale or distribution, or the applicable authority to sell or distribute under the rules, to apply to the Central Licensing Authority.
The authorised agent represents the overseas manufacturer for Indian regulatory purposes and assumes responsibilities connected with the manufacturer’s business activities in India under the import licence.
Therefore, a European manufacturer cannot simply treat a foreign commercial exporter as the Indian applicant. The parties should confirm the Indian entity’s regulatory eligibility before compiling the dossier.
The manufacturer’s authorisation should also correctly identify the parties, manufacturing relationship and regulatory scope. Current CDSCO documentation specifies authenticated power-of-attorney documentation for the import process.
Apply for the Indian Import Licence
CDSCO identifies Form MD-14 as the application for a medical-device import licence and Form MD-15 as the licence granted by the Central Licensing Authority. CDSCO currently provides electronic submission for this import pathway.
Form MD-15 identifies the overseas manufacturer, manufacturing site and licensed devices. Its annexure records device-specific particulars such as generic name, model, intended use, class, construction material, dimensions where applicable, shelf life and sterile status.
Consequently, one approval should not be treated as unrestricted authority to import everything produced by a European manufacturer. Additional manufacturing sites or devices can require further applications, documents and applicable fees.
Class A Non-Sterile, Non-Measuring Devices Need Separate Attention
Importers should identify whether a product falls within the exemption introduced for Class A non-sterile and non-measuring medical devices. CDSCO distinguishes this category from devices requiring the standard import licence and applies registration requirements to it.
Therefore, an importer should not automatically prepare Form MD-14 merely because a product meets the medical-device definition. First determine its class and whether the current exemption applies.
Prepare Manufacturer and Device Documentation
The Fourth Schedule and current CDSCO checklist structure the evidence supporting an import application. Documentation varies with the device and circumstances, so applicants should distinguish core records from evidence triggered by particular regulatory issues.
A dossier can involve:
- Indian applicant information;
- manufacturer and manufacturing-site details;
- authorised-agent documentation;
- regulatory certificates;
- quality-system evidence;
- declaration of conformity;
- applicable European conformity certificates;
- Free Sale or marketing-authorisation evidence where relevant;
- Plant Master File information;
- Device Master File information;
- labels and instructions for use; and
- applicable safety, performance and validation evidence.
Names, addresses, model identifiers and manufacturing-site information should remain consistent across the dossier. Small discrepancies can create significant regulatory questions because the licence links specific devices with a specific overseas manufacturing site.
A medical device license consultant in West Bengal may assist with classification review, applicant documentation, dossier organisation, labelling review and downstream compliance coordination, but professional support does not replace the authorised agent, manufacturer or competent regulatory authorities.
Technical Evidence Must Match the Device
A Device Master File provides device-specific regulatory information rather than merely repeating a European certificate. CDSCO’s checklist covers areas including an executive summary, descriptive information, grouping justification, specifications, variants, accessories, labelling, design and manufacturing information.
Depending on the device, technical evidence may also address risk management, verification, validation, biocompatibility, electrical safety, software, sterilisation, shelf life or clinical performance.
Not every device needs identical evidence. An implantable Class D product presents different questions from a simple lower-risk non-active device, while an IVD may require performance evidence relevant to its diagnostic purpose.
Consequently, dossier preparation should follow the product rather than a universal technical-document template.
Manufacturing Site and Quality System Matter
Indian import licensing connects the approved device with its overseas manufacturing site. The application therefore requires sufficient information about the actual site and its quality arrangements.
ISO 13485 certification can provide significant quality-management evidence where applicable. However, holding ISO 13485 certification does not independently authorise commercial import into India.
Applicants should check that certificates cover the correct site and relevant scope. A certificate naming a corporate headquarters while the device comes from another manufacturing facility can create an avoidable mismatch.
Moreover, the Central Licensing Authority may cause an overseas manufacturing-site inspection during import-licence scrutiny. The rules make this a regulatory power rather than an automatic inspection requirement for every European site.
Free Sale Evidence and Market History Need Care
Market evidence can influence the regulatory pathway, particularly where Indian rules distinguish devices already authorised in specified jurisdictions from other products.
European regulatory status may therefore contribute meaningful evidence, but applicants should establish precisely what the Indian pathway requires for their device. A Free Sale Certificate does not mean the same thing as a declaration of conformity or notified-body certificate.
Likewise, CE marking does not automatically waive Indian clinical evidence for an investigational device. CDSCO has clarified that particular clinical-investigation exemptions depend on conditions specified in the rules rather than CE status alone.
A newly developed product without the necessary regulatory or market evidence may consequently require additional safety, performance, clinical or other prescribed evidence.
Testing Depends on Regulatory Circumstances
Import licensing does not mean customs or CDSCO routinely retests every commercial device entering India. However, the Central Licensing Authority can require evaluation, testing or examination where it has reason to believe device quality may have become compromised.
Other testing requirements depend on the device. Relevant evidence can include manufacturer testing against recognised standards, validation studies or performance evaluation for applicable IVDs.
For non-commercial quantities intended for clinical investigation, testing, evaluation, demonstration or training, the Medical Devices Rules provide a separate pathway. Form MD-16 applies to the application, while Form MD-17 represents the resulting test licence.
Commercial importers should therefore avoid using test-import permissions as substitutes for market authorisation.
Adapt Labelling for the Indian Market
European packaging does not automatically satisfy Indian medical-device labelling rules. Rule 44 prescribes particulars for medical-device labels, subject to the requirements applicable to the product.
Importers should check relevant particulars covering:
- device identification;
- manufacturer information;
- batch, lot or serial identification where applicable;
- manufacturing and expiry information where required;
- storage or handling conditions;
- sterile status where applicable;
- warnings and precautions;
- importer information; and
- Indian import-licence details where required.
CDSCO has clarified that specified India-specific information can, where permitted, appear through stickering when it does not already appear on the original label. Such particulars include the import-licence number, importer information and manufacturing-premises information.
Any separate packaged-commodity obligations should receive product-specific assessment rather than automatic application to every device.
Customs Clearance Remains a Separate Stage
An MD-15 licence addresses medical-device import authorisation; it does not replace customs formalities.
Before shipment, the importer should coordinate the applicable customs classification and documentation. Depending on the transaction, the clearance file can involve:
- Importer Exporter Code requirements;
- Bill of Entry;
- commercial invoice;
- packing list;
- country-of-origin documentation where applicable;
- medical-device import authorisation;
- shipment and transport documents; and
- other product-specific customs evidence.
Tariff classification matters because duties and taxes can differ by product. Consequently, importers should not apply one assumed medical-device duty rate across unrelated devices.
An Importer Exporter Code serves a trade and customs function. It does not constitute CDSCO authorisation to market a regulated medical device.
West Bengal Distribution Creates a Separate Layer
CDSCO’s Central Licensing Authority controls the primary import-licence pathway. West Bengal does not issue a substitute central import licence merely because the importer warehouses or markets devices within the state.
However, downstream sale and distribution require separate attention. The Medical Devices Rules require a person intending to sell, stock, exhibit, offer for sale or distribute regulated medical devices to apply to the concerned State Licensing Authority in Form MD-41 for a registration certificate in Form MD-42, subject to the applicable framework.
The application framework addresses premises, applicant constitution, competent technical staff, Good Distribution Compliance and storage undertakings. Therefore, obtaining MD-15 does not eliminate state-level obligations attached to downstream commercial distribution.
Storage Must Follow Product Requirements
Warehousing arrangements should preserve the safety, performance and integrity of imported devices throughout their distribution life.
Relevant controls may include:
- labelled temperature and humidity conditions;
- cold-chain arrangements where required;
- protection against contamination or physical damage;
- maintenance of sterile-package integrity;
- segregation of damaged, expired or recalled stock;
- suitable stock rotation; and
- traceable receipt and dispatch records.
Not every medical device needs refrigerated or temperature-controlled warehousing. A durable non-sterile device may tolerate conditions that would be unsuitable for a temperature-sensitive IVD reagent.
Accordingly, the manufacturer’s validated storage conditions should drive warehouse controls.
Maintain Distribution Traceability
Traceability becomes particularly important if a manufacturer later identifies a safety or performance problem.
Records should enable the responsible business to connect imported stock with its distribution chain through relevant lot, batch or serial information. Invoices and dispatch records should also support identification of recipients where required.
Under the medical-device sale-registration framework, prescribed registers and records must remain available for regulatory inspection, and the rules require preservation for at least two years from the last entry. Registration holders must also maintain the prescribed inspection book in Form MD-43.
Device-specific obligations can require additional controls, so businesses should avoid treating that period as a universal limit for every regulatory record.
Post-Market Responsibility Continues After Import
Customs clearance does not end regulatory responsibility. Importers and authorised agents need systems for complaints, product-quality concerns, safety signals, corrective actions and communication with the overseas manufacturer.
Where a serious device-related issue arises, the responsible parties should determine whether Indian vigilance reporting or regulatory communication applies. Routine commercial complaints and reportable safety incidents do not necessarily receive identical regulatory treatment.
If the European manufacturer initiates a field safety corrective action, the Indian parties should identify affected stock, control further distribution where necessary, trace supplied units and coordinate the action required under Indian requirements.
European action alone should not substitute for applicable Indian post-market responsibilities.
Control Changes After Approval
Import approval reflects specified manufacturer, site and device information. Consequently, post-approval changes require regulatory assessment before implementation in India.
Relevant changes can involve:
- overseas manufacturer details;
- manufacturing location;
- authorised agent;
- model or device grouping;
- intended purpose;
- design or material;
- sterilisation;
- shelf life;
- labelling; or
- other approved particulars.
Not every change requires a fresh import licence. The required regulatory action depends on the nature and significance of the change.
Similarly, acceptance of a design or quality-system change under EU MDR or IVDR does not automatically establish acceptance under Indian requirements.
Import Licence Validity Uses a Retention Framework
An MD-15 import licence remains valid in perpetuity unless it undergoes cancellation or surrender, provided the authorised agent pays the prescribed retention fee after every five-year period in accordance with the Medical Devices Rules. Failure to meet the retention requirements can affect continued licence validity.
Therefore, businesses should not treat MD-15 as a traditional licence that simply expires and undergoes ordinary renewal at a fixed date.
Downstream Form MD-42 registration similarly operates through continuing validity subject to the prescribed five-year retention-fee framework unless suspension or cancellation occurs.
Avoid Common Import and Compliance Errors
Frequent regulatory problems arise when commercial planning moves ahead of product-specific review. Importers should prevent:
- incorrect Indian risk classification;
- direct conversion of an EU class into an Indian class;
- incomplete manufacturer authorisation;
- inconsistent device or site names;
- outdated regulatory certificates;
- incomplete technical documentation;
- unsuitable market-authorisation evidence;
- incorrect application scope;
- Indian labelling deficiencies;
- shipment of models outside approved scope;
- storage contrary to labelled conditions; and
- loss of distribution traceability.
After approval, businesses should also assess regulatory consequences before changing sites, models, labels or authorised agents.
Complete a Pre-Shipment Regulatory Check
Before releasing a commercial shipment from Europe, confirm that:
- Indian medical-device status has been established.
- Indian classification has been confirmed.
- The correct applicant or authorised agent is in place.
- Manufacturer and manufacturing-site information matches the approval.
- The required Indian import authorisation or registration pathway is complete.
- Shipped models fall within approved scope.
- Indian labelling requirements have been addressed.
- Customs documentation and IEC requirements are ready.
- Storage arrangements match labelled conditions.
- West Bengal sale or distribution requirements have been addressed.
- Distribution traceability systems operate.
- Complaint, vigilance and corrective-action procedures are ready.
A shipment should follow the approved regulatory configuration rather than force regulatory documentation to match goods already dispatched.
Conclusion
Importing European medical devices for the West Bengal market requires coordination across Indian classification, central import regulation, manufacturer evidence, authorised-agent eligibility, labelling and customs clearance. Distribution inside West Bengal adds premises, storage, sale-registration and traceability considerations where applicable.
European conformity evidence can support an Indian regulatory submission, but it cannot replace the Indian pathway. Before shipment, importers should verify that the approved manufacturer, site, device models, labels and commercial distribution arrangements align with current Indian requirements and that post-market systems can support the products after supply.
FAQs
1. Does CE marking allow direct import of a medical device into India?
No. CE marking can provide relevant regulatory and conformity evidence, but it does not constitute Indian import authorisation. The importer must determine the applicable Indian pathway under the Medical Devices Rules, including classification, applicant eligibility and import licensing or registration requirements before commercial import.
2. Who issues a medical device import licence in India?
The Central Licensing Authority grants the medical-device import licence under the Medical Devices Rules. For devices following the standard import-licence pathway, the authorised agent submits Form MD-14 and the authority grants the licence in Form MD-15 after satisfactory regulatory review and compliance with applicable requirements.
3. Does West Bengal issue a separate medical device import licence?
West Bengal does not replace the central MD-15 import-licence framework. However, businesses selling, stocking or distributing regulated medical devices in West Bengal must separately consider the state-level sale-registration framework, including Form MD-41 and Form MD-42 requirements, where applicable to their downstream activities.
4. Who can act as an Indian authorised agent?
Under the standard import pathway, the authorised agent must satisfy the eligibility requirements prescribed by the Medical Devices Rules and hold the applicable authority for manufacture or sale and distribution. The overseas manufacturer authorises that Indian entity to perform regulatory responsibilities associated with the imported devices.
5. How does India classify imported medical devices?
India uses a risk-based system comprising Classes A, B, C and D, progressing from low to high risk. IVDs also follow classification principles under the Medical Devices Rules. European classification should not be copied directly because Indian classification depends on India’s applicable rules and the device’s intended purpose.
6. Which documents does a European manufacturer usually provide?
Depending on the product and pathway, the manufacturer may need to provide site information, quality-system evidence, regulatory certificates, conformity documentation, Free Sale or marketing evidence where applicable, Device Master File information, labels, instructions and technical safety or performance evidence required for the particular device.
7. Does every imported medical device require testing in India?
No universal requirement makes every commercial imported device undergo routine Indian testing. However, testing, evaluation or performance evidence can become necessary depending on the product and regulatory circumstances. The Central Licensing Authority can also require evaluation or testing if it has concerns about device quality.
8. Can one import licence cover several medical device models?
An MD-15 licence identifies the approved overseas manufacturer, manufacturing site and medical devices, including relevant model information. Grouping principles may permit appropriate products within an application, but an importer should not assume that the licence covers every model manufactured at that site.
9. What labelling changes may a European medical device need for India?
Imported devices must satisfy applicable Indian labelling requirements. India-specific information can include importer and import-licence particulars alongside other prescribed device information. CDSCO permits specified information through stickering in applicable circumstances when the original packaging does not already contain those required particulars.
10. What compliance continues after devices enter West Bengal?
Businesses must continue controlling lawful storage, sale and distribution, traceability, records, complaints and relevant post-market safety actions. Applicable state sale-registration obligations also continue after import. Changes to approved devices, manufacturing sites or regulatory arrangements may require further action before the altered configuration enters Indian commerce.
